| 000 | 01683 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515113125.0 | ||
| 264 | 0 | _c20090108 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a0770-3198 | ||
| 024 | 7 |
_a10.1007/s10067-008-0866-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan der Bijl, Arie E | |
| 245 | 0 | 0 |
_aAn open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cAug 2008 |
||
| 300 |
_a1021-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdalimumab |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBreedveld, Ferdinand C | |
| 700 | 1 | _aAntoni, Christian E | |
| 700 | 1 | _aKalden, Joachim R | |
| 700 | 1 | _aKary, Sonja | |
| 700 | 1 | _aBurmester, Gerd R | |
| 700 | 1 | _aBeckmann, Christina | |
| 700 | 1 | _aUnnebrink, Kristina | |
| 700 | 1 | _aKupper, Hartmut | |
| 773 | 0 |
_tClinical rheumatology _gvol. 27 _gno. 8 _gp. 1021-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-008-0866-4 _zAvailable from publisher's website |
| 999 |
_c17851450 _d17851450 |
||